Elastic NV ESTC Q1 2026 Results Top Views on Strong Revenue Geopolitical Focus Taiwan Arms Sales Emerge as Key Point in TrumpXi Talks Enliven Therapeutics ELVN Delivers Q1 2026 Beat EPS 038 vs 047 Expected Archrock AROC Surges 210 Nearing 4078 Resistance 20260520